Security key
M74240108
NeuroSense Therapeutics Ltd. - ORDINARY SHARES (NRSN)
CUSIP: M74240108
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / ORDINARY SHARES
- Total 13F shares
- 168,852
- Total 13F value
- $694,000
- Share change
- -1,610
- SEC-reported price per share
- $3.94
- Number of holders
- 7
- Value change
- +$264,799
- Number of buys
- 5
- Number of sells
- 6
Report period
Q1 2022
Institutions
7
Top holders
7
NRSN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NeuroSense Therapeutics Ltd. SEC filings
NeuroSense Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M74240108
Recent filing periods:
Ownership snapshot
Top reported holders of NRSN - NeuroSense Therapeutics Ltd. - ORDINARY SHARES (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/7
Latest evidence
31 Dec 2021
13F
Highest disclosed value: $388,000
7 rows are not safely comparable across share classes.
Showing 1-6 of 7 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $388K.
0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$388K
Hudson Bay Capital Management LP
$321K
CITADEL ADVISORS LLC
$135K
Warberg Asset Management LLC
$99K
UBS Group AG
$24K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$388,000
425,000 shares
|
— | 31 Dec 2021 |
| Hudson Bay Capital Management LP |
13F
Company
|
—
mixed-class rows
|
$321,000
225,000 shares
mixed-class rows
|
— | 31 Dec 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$135,000
55,119 shares
|
— | 31 Dec 2021 |
| Warberg Asset Management LLC |
13F
Company
|
—
mixed-class rows
|
$99,000
82,107 shares
mixed-class rows
|
— | 31 Dec 2021 |
| UBS Group AG |
13F
Company
|
—
mixed-class rows
|
$24,000
12,509 shares
mixed-class rows
|
— | 31 Dec 2021 |
| Empery Asset Management, LP |
13F
Company
|
—
class O/S missing
|
$15,000
160,000 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
168,852
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2026 Across Filers
Q1 2026 holders
13
Q1 2022 holders
7
Holder diff
-6
| Investor | Q1 2026 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend